Literature DB >> 8143885

Possible mechanisms of alteration in the capacities of carcinogen metabolizing enzymes during schistosomiasis and their role in bladder cancer induction.

A F Badawi1, M H Mostafa.   

Abstract

Carcinoma of the urinary bladder is the most common malignancy in many tropical and subtropical countries. There is a well documented association with chronic urinary schistosomal infection, and bladder cancer associated with schistosomiasis is a major cause of morbidity and mortality in the endemic areas. Many factors have been suggested as possible causative agents in schistosome-associated bladder carcinogenesis but theories concerning the possible role of schistosomal infection in altering host metabolism of chemical carcinogens have received most attention. In experimental schistosomiasis there is a common pattern of changes in the activities of several hepatic Phase I and Phase II enzymes. Phase I enzymes show increased activities in the early stages of infection but these activities are reduced to below their preinfection levels in the intermediate and late chronic stages of the disease. The activities of Phase II enzymes are altered in favour of the deconjugation pathways in the later stages of the disease. The possible basic mechanisms that might be involved in such changes during parasitism and their potential role in the induction of bladder neoplasia are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8143885     DOI: 10.1177/030006059302100601

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  4 in total

1.  Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.

Authors:  Naglaa El-Lakkany; Sayed Hassan Seif El-Din; Lamia Heikal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-03-30       Impact factor: 2.441

Review 2.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

3.  Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.

Authors:  Eglal I Amer; Iman Fathy Abou-El-Naga; Laila M Boulos; Heba S Ramadan; Salwa S Younis
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

4.  Effect of ketoconazole, a cytochrome P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosoma mansoni in mice.

Authors:  Sayed Hassan Seif El-Din; Abdel-Nasser Abdel-Aal Sabra; Olfat Ali Hammam; Naglaa Mohamed El-Lakkany
Journal:  Korean J Parasitol       Date:  2013-04-25       Impact factor: 1.341

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.